Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

AZN

Astrazeneca plc ADR

Jan 16 • 02:49PM ET

94.41

+0.42 0.45 %

Healthcare • Drug Manufacturers - General • United Kingdom • NASD

Peers: ABBV PFE JNJ MRK NVS BMY GSK SNY LLY AMGN

| Held by: QQQ QQQM PVAL TQQQ AVDE DIHP DFIC PPH QQEW FVD

Scroll to Statements

Index	NDX	P/E	31.32	EPS (ttm)	3.01	Insider Own	0.03%	Shs Outstand	3.10B	Perf Week	-0.25%
Market Cap	292.76B	Forward P/E	18.41	EPS next Y	5.13	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	3.35%
Enterprise Value	317.29B	PEG	1.54	EPS next Q	1.06	Inst Own	16.16%	Short Float	0.35%	Perf Quarter	12.62%
Income	9.41B	P/S	5.04	EPS this Y	11.60%	Inst Trans	-3.84%	Short Ratio	2.11	Perf Half Y	37.24%
Sales	58.12B	P/B	6.38	EPS next Y	11.95%	ROA	8.58%	Short Interest	10.94M	Perf YTD	2.70%
Book/sh	14.80	P/C	35.78	EPS next 5Y	11.93%	ROE	21.73%	52W High	96.51 -2.18%	Perf Year	43.74%
Cash/sh	2.64	P/FCF	22.57	EPS past 3/5Y	285.92% 34.53%	ROIC	13.08%	52W Low	61.24 54.16%	Perf 3Y	34.01%
Dividend Est.	1.63 (1.72%)	EV/EBITDA	16.47	Sales past 3/5Y	12.66% 17.18%	Gross Margin	73.25%	Volatility	1.69% 1.53%	Perf 5Y	86.73%
Dividend TTM	1.56 (1.66%)	EV/Sales	5.46	EPS Y/Y TTM	44.28%	Oper. Margin	21.89%	ATR (14)	1.73	Perf 10Y	197.17%
Dividend Ex-Date	Aug 08, 2025	Quick Ratio	0.69	Sales Y/Y TTM	12.95%	Profit Margin	16.19%	RSI (14)	56.77	Recom	1.59
Dividend Gr. 3/5Y	2.54% 2.10%	Current Ratio	0.88	EPS Q/Q	74.53%	SMA20	1.38%	Beta	0.35	Target Price	102.49
Payout	66.95%	Debt/Eq	0.71	Sales Q/Q	10.18%	SMA50	3.76%	Rel Volume	1.51	Prev Close	93.99
Employees	94300	LT Debt/Eq	0.57	Earnings	Nov 06 BMO	SMA200	19.79%	Avg Volume	5.19M	Price	94.41
IPO	May 12, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.80% 2.79%	Trades		Volume	6,479,261	Change	0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-25	Resumed	Jefferies	Buy
Oct-16-25	Downgrade	Deutsche Bank	Hold → Sell
Apr-15-25	Initiated	Exane BNP Paribas	Outperform	$75
Feb-13-25	Upgrade	UBS	Neutral → Buy
Feb-12-25	Initiated	Morgan Stanley	Overweight
Nov-20-24	Upgrade	UBS	Sell → Neutral
Nov-06-24	Upgrade	Deutsche Bank	Sell → Hold
Sep-13-24	Downgrade	Deutsche Bank	Hold → Sell
May-30-24	Initiated	Goldman	Buy	$97
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight

Show Previous Ratings

Today 12:31PM	Health Care Roundup: Market Talk (The Wall Street Journal)
07:46AM	Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading (Benzinga)
Jan-15-26 03:13PM	NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading (The Wall Street Journal)
03:10PM	Trump unveils his 'Great Healthcare Plan.' Analysts don't expect much of an impact. (MarketWatch)
08:21AM	What Makes AstraZeneca (AZN) a Strong Growing Company? (Insider Monkey)
06:05AM	Loading…
06:05AM	AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference (MarketBeat)
03:22AM	The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company) (Motley Fool)
Jan-14-26 06:15PM	Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note (Zacks)
01:20PM	JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition (Pharmaceutical Technology)
09:35AM	Will Keytruda Continue to Aid Merck's Top Line in Q4 Earnings? (Zacks)
09:00AM	Looking to Sell America Amid Fed Drama? Heres 1 ETF to Buy. (Barchart)
07:45AM	PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock (Zacks)
Jan-13-26 04:51PM	AstraZeneca CFO on M&A Strategy and Obesity Market (Bloomberg)
12:09PM	AstraZeneca to acquire Modella AI to speed oncology drug research (Reuters)
08:43AM	Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings? (Zacks)
07:54AM	Loading…
07:54AM	Inside Pfizer's Oncology Performance Ahead of Q4 Results (Zacks)
07:09AM	Walmart Stock Gaining Steam Ahead of Debut on Nasdaq-100 (Zacks)
Jan-12-26 04:34PM	Walmart Stock Is Rising. Its Not Just a Google AI Deal Giving It a Boost. (Barrons.com)
01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
01:23PM	Is Walmart a Tech Stock? Its Planned Move to the Nasdaq 100 Is a Vote for 'Yes' (Investopedia)
01:08PM	Tempus AI's Pharma Momentum Accelerates (GuruFocus.com)
09:39AM	Stocks to Watch Monday: Capital One, UnitedHealth, Walmart, Exxon (The Wall Street Journal)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
Jan-10-26 02:57PM	Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) - Here's Why (Insider Monkey)
Jan-09-26 09:09PM	Walmart To Join Nasdaq 100 on Jan. 20 as AstraZeneca Exits (Bloomberg)
11:40AM	Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond (Zacks)
10:51AM	J&J Strikes Drug Pricing Deal With Trump, Gets Tariff Reprieve (Zacks)
07:23AM	J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts (Pharmaceutical Technology)
Jan-08-26 06:15PM	Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:50AM	Here's Why Astrazeneca (AZN) is a Strong Momentum Stock (Zacks)
08:57AM	Loading…
08:57AM	J&J's Innovative Medicine Segment in Q4: Here's What to Watch (Zacks)
07:00AM	Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit (Business Wire)
06:30AM	Asia Has Become Epicenter of Prescription Drug Innovation: McKinsey (The Daily Upside)
Jan-07-26 08:33AM	Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline (Zacks)
Jan-06-26 12:44PM	FTSE hits new record as global markets edge higher (The Telegraph)
11:51AM	JNJ vs. AZN: Which Drug Stock Comes Out on Top for Investors? (Zacks)
09:45AM	Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Jan-05-26 03:00AM	3 of Chinas most innovative pharma companies (Pharma Voice)
Jan-02-26 01:55PM	These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year. (Barrons.com)
Dec-31-25 07:01AM	The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies (Zacks)
Dec-30-25 02:04PM	Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel (Zacks)
Dec-29-25 02:20PM	Alibaba Was the Markets Favorite Chinese AI Stock in 2025: Whats BABAs 2026 Forecast? (Barchart)
Dec-26-25 03:00PM	QBTS or IONQ: Which Quantum Computing Stock Will Lead in 2026? (Zacks)
08:21AM	Can J&J's Pipeline Progress in 2025 Aid Long-Term Growth? (Zacks)
04:30AM	China's rising biotech clout on show in flurry of billion-dollar licensing deals (South China Morning Post)
Dec-24-25 11:20AM	PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth (Zacks)
Dec-23-25 10:51AM	ABBV vs. AZN: Which Pharma Stock is the Better Investment Now? (Zacks)
09:48AM	Stock Market Today: Dow Slips After Strong GDP Data; Novo Soars On Weight-Loss Pill (Live Coverage) (Investor's Business Daily)
09:40AM	Here's Why Astrazeneca (AZN) is a Strong Value Stock (Zacks)
08:48AM	5 Big Drug Stocks That May Continue to Outperform in 2026 (Zacks)
03:53AM	J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant (Revised) (Zacks)
03:13AM	AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Revised) (Zacks)
Dec-22-25 10:25AM	AZN, Daiichi's Enhertu Gets Breakthrough Tag for Expanded Cancer Use (Zacks)
07:00AM	ENHERTU (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer (Business Wire)
02:39AM	AstraZeneca Drug Combination Falls Short of Goal in Lung-Cancer Trial (The Wall Street Journal)
Dec-21-25 10:38PM	Jacobio Strikes New Cancer Drug Deal with AstraZeneca (Bloomberg)
Dec-19-25 05:40PM	Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump (Investor's Business Daily)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
02:53PM	AstraZeneca PLC (AZN) Announces Approval of Saphnelo by the European Union (Insider Monkey)
10:46AM	Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock (Zacks)
10:32AM	Can Merck Successfully Steer Through the Upcoming Headwinds? (Zacks)
Dec-18-25 08:50PM	3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now (Motley Fool)
12:48PM	J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant (Zacks)
Dec-16-25 10:43AM	AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Zacks)
09:45AM	Here's Why Astrazeneca (AZN) is a Strong Growth Stock (Zacks)
Dec-15-25 06:15PM	Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts (Zacks)
04:29PM	ENHERTU (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer (Business Wire)
Dec-12-25 10:03AM	Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE? (Zacks)
07:42AM	AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock (Zacks)
07:33AM	AstraZeneca (AZN) At the Center of Serious Analyst Attention (Insider Monkey)
Dec-11-25 09:12AM	GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell? (Zacks)
07:49AM	Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth (Zacks)
Dec-10-25 11:28AM	Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In? (Insider Monkey)
08:12AM	Transamericas Owner Is Moving to the U.S. (The Wall Street Journal)
Dec-09-25 11:50AM	Pfizer Turns to China for Trial Weight Loss Drug. Congress Is Worried About Chinese Biotechs. (Barrons.com)
Dec-05-25 05:00AM	Praxis soars higher; Bristol Myers CAR-T therapy wins broader use (BioPharma Dive)
Dec-04-25 04:00PM	Salesforces Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement (Business Wire)
07:00AM	AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH (Business Wire)
03:00AM	BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again? (Pharma Voice)
Dec-03-25 10:01AM	AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension (Zacks)
09:50AM	Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term (Zacks)
07:28AM	Win for pharma in UK zero US tariffs, VPAG rate cap and NICE threshold increase (Pharmaceutical Technology)
01:57AM	AstraZeneca (AZN) Named One of BofA's Top 25 Stocks for 2026 (Insider Monkey)
Dec-02-25 10:24AM	Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure (Zacks)
09:18AM	Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension (Business Wire)
05:15AM	Janux sinks on overreaction to prostate cancer data; RFK Jr. replaces ACIP chair (BioPharma Dive)
12:00AM	Will the next blockbuster drug come from China? (Financial Times)
Dec-01-25 01:33PM	U.S., U.K. Strike Deal on Higher Drug Prices (The Wall Street Journal)
12:17PM	Theres a once-in-a-generation opportunity in these stocks right now, no matter how the AI boom ends, market veteran says (Fortune)
11:00AM	AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
07:34AM	Shares of vaccine makers drop after FDA memo flags reports of child deaths (Investing.com)
06:12AM	AstraZeneca to invest $2B in Maryland manufacturing expansion (Manufacturing Dive)
Nov-28-25 10:03AM	JNJ's Oncology Momentum Builds as It Chases $50B Goal by 2030 (Zacks)
09:45AM	Here's Why Astrazeneca (AZN) is a Strong Growth Stock (Zacks)
Nov-27-25 09:45AM	AstraZeneca or Merck: Which Oncology Giant Has the Edge? (Zacks)
09:40AM	Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term (Zacks)
Nov-26-25 04:11PM	Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied (Investor's Business Daily)
09:49AM	Will Soft Gardasil Demand Continue to Dampen Merck's Top Line? (Zacks)
Nov-25-25 07:57PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
07:24AM	J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock? (Zacks)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company's history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ARADHANA SARIN	Officer	Nov 12 '25	Proposed Sale	88.88	15,000	1,333,200		Nov 12 05:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc ADR

Upgrade your FINVIZ experience